CLINICAL TRIALS PROFILE FOR TORSEMIDE
✉ Email this page to a colleague
All Clinical Trials for TORSEMIDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00334386 ↗ | Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension. | Completed | Ferrer Internacional S.A. | Phase 4 | 2005-04-01 | Primary objective:To demonstrate the no-inferiority in efficacy of treatment with Torsemide-PR in relation to Torsemide-IR in patients with mild and/or moderate hypertension. Secondary objectives: To evaluate the safety and tolerability of Torsemide-PR. |
NCT00602303 ↗ | Bioequivalency Study of Torsemide Tablets Under Fasting Conditions | Completed | Roxane Laboratories | N/A | 2003-09-01 | The objective of this study was the bioequivalence of a Roxane Laboratories' Torsemide Tablets, 20 mg, to Demadex® Tablets, 20 mg (Roche) under fasting conditions using a single-dose, 2-treatment, 2-period, crossover design. |
NCT00602615 ↗ | Bioequivalency Study of Torsemide Tablets Under Fed Conditions | Completed | Roxane Laboratories | N/A | 2003-09-01 | The objective of this study was the bioequivalence of a Roxane Laboratories' Torsemide Tablets, 20 mg, to Demadex® Tablets, 20 mg (Roche) under fed conditions using a single-dose, 2-treatment, 2-period, crossover design. |
NCT00653549 ↗ | Bioavailability Study of Torsemide Tablets Under Fasting Conditions | Completed | Anapharm | Phase 1 | 2001-04-01 | To compare the single-dose bioavailability of Torsemide tablets with Demadex |
NCT00653549 ↗ | Bioavailability Study of Torsemide Tablets Under Fasting Conditions | Completed | Par Pharmaceutical, Inc. | Phase 1 | 2001-04-01 | To compare the single-dose bioavailability of Torsemide tablets with Demadex |
NCT00654043 ↗ | Bioavailability Study of Torsemide Tablets Under Fed Conditions | Completed | Anapharm | Phase 1 | 2001-04-01 | To compare the single-dose bioavailability of Torsemide tablets with Demadex |
NCT00654043 ↗ | Bioavailability Study of Torsemide Tablets Under Fed Conditions | Completed | Par Pharmaceutical, Inc. | Phase 1 | 2001-04-01 | To compare the single-dose bioavailability of Torsemide tablets with Demadex |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TORSEMIDE
Condition Name
Clinical Trial Locations for TORSEMIDE
Trials by Country
Clinical Trial Progress for TORSEMIDE
Clinical Trial Phase
Clinical Trial Sponsors for TORSEMIDE
Sponsor Name